Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00236-X/fulltext?dgcid=hubspot_update_feature_updatealerts_landia&utm_campaign=update-landia&utm_medium=email&_hsmi=281563855&_hsenc=p2ANqtz-9Qk48HlB7w0bNv9ij-g5MA_m4wrYC3_MHi_Q8cmWfUhXFEO6uB50xI5-Es6fvEWZf01u7r29jV_HAPojbggHdI0mEi0Q&utm_content=281534679&utm_source=hs_email